GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $331,000 | -86.1% | 2,700 | -88.1% | 0.24% | +92.1% |
| Q4 2019 | $2,379,000 | +1049.3% | 22,751 | +971.1% | 0.13% | +950.0% |
| Q4 2018 | $207,000 | -93.9% | 2,124 | -89.2% | 0.01% | -94.2% |
| Q3 2018 | $3,390,000 | +663.5% | 19,624 | +343.6% | 0.21% | +221.9% |
| Q2 2017 | $444,000 | +226.5% | 4,424 | +293.6% | 0.06% | +146.2% |
| Q1 2017 | $136,000 | -90.1% | 1,124 | -89.1% | 0.03% | -93.5% |
| Q3 2016 | $1,367,000 | +897.8% | 10,300 | +442.1% | 0.40% | +587.9% |
| Q1 2016 | $137,000 | +226.2% | 1,900 | +216.7% | 0.06% | +100.0% |
| Q4 2015 | $42,000 | +55.6% | 600 | +100.0% | 0.03% | +26.1% |
| Q3 2015 | $27,000 | -84.3% | 300 | -81.2% | 0.02% | -86.1% |
| Q2 2014 | $172,000 | – | 1,600 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |